BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 31625123)

  • 1. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway.
    Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS
    Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways.
    Tong L; Wu W
    Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
    J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
    Hu BS; Xiong SM; Li G; Li JP
    Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
    J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
    Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J
    Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma.
    Gan Y; Han N; He X; Yu J; Zhang M; Zhou Y; Liang H; Deng J; Zheng Y; Ge W; Long Z; Xu X
    Tumour Biol; 2017 Jun; 39(6):1010428317706229. PubMed ID: 28621238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
    Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
    Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
    Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
    J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway.
    Liao S; Chen H; Liu M; Gan L; Li C; Zhang W; Lv L; Mei Z
    Aging (Albany NY); 2020 Jan; 12(2):1527-1544. PubMed ID: 31969493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 19. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.
    Zhao L; Zhang Y; Zhang Y
    J Cell Physiol; 2018 Oct; 233(10):6661-6670. PubMed ID: 29319182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA CCAL promotes hepatocellular carcinoma progression by regulating AP-2α and Wnt/β-catenin pathway.
    Liu Y; Yang Y; Wang T; Wang L; Wang X; Li T; Shi Y; Wang Y
    Int J Biol Macromol; 2018 Apr; 109():424-434. PubMed ID: 29275200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.